• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

692 Anticoagulation Prescription for Indigenous and Non-Indigenous Patients With Atrial Fibrillation in Central Australia
This study sought to compare anticoagulant prescribing practices in Indigenous and non-Indigenous Australians with AF in Central Australia.
Source: Heart, Lung and Circulation - November 8, 2020 Category: Cardiology Authors: N. Clarke, C. Gallagher, B. Pitman, S. Tu, N. Hanna-Rivero, N. Kangaharan, K. Roberts-Thomson, D. Lau, R. Mahajan, P. Sanders, C. Wong Source Type: research

516 Non-Vitamin K Anticoagulation for Non-Valvular Atrial Fibrillation in Regional Australia
Non-vitamin K antagonist oral anticoagulants (NOACs) are the therapy of choice for stroke prevention in patients with non-valvular atrial fibrillation and at least one risk factor. The Illawarra-Shoalhaven region local health district provides health services for around 400,000 people. In regional centres, many AF patients are managed by GPs. The purpose of this study was to identify the proportion of patients with NVAF who were prescribed different NOACs as well as determine if the dosage follows current guidelines.
Source: Heart, Lung and Circulation - November 8, 2020 Category: Cardiology Authors: J. Moragues Source Type: research

The role of CHA2DS2-VASc score in evaluating patients with atrial fibrillation undergoing percutaneous coronary intervention
Objective The aim of the review was to assess whether CHA2DS2-VASc score is predictive of mortality in patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI). Background The CHA2DS2-VASc score is validated in predicting stroke risk in atrial fibrillation. The optimum management strategy for these patients undergoing PCI is still debated. Methods The CHA2DS2-VASc score was calculated in consecutive patients with atrial fibrillation undergoing PCI in a large Australian registry between 2007 and 2013. Patients were divided into low (1–2), intermediate (3–4) and high (≥5) ...
Source: Coronary Artery Disease - May 6, 2021 Category: Cardiology Tags: PCI/Coronary Angiography Source Type: research

Appropriateness of inpatient dosing of direct oral anticoagulants for atrial fibrillation
The objective was to determine the rates of inappropriate inpatient DOAC dosing in AF and identifying its associated underlying factors. We conducted a retrospective cross-sectional study from December 2013 to November 2019 across six South Australian public hospitals utilising a centralised electronic health record. Multivariate analysis was used to identify factors associated with underdosing of patients prescribed apixaban. Of 1882 inpatients, 544 (28.9  %) were inappropriately dosed. Underdosing was the most common form of inappropriate dosing with rates of 22.9 % (n = 295), 7.1 % (n = 7), and 25.1 % (n...
Source: Journal of Thrombosis and Thrombolysis - July 24, 2021 Category: Hematology Source Type: research

Pilot experience using a portable electrocardiography device for atrial fibrillation detection in an outpatient stroke clinic
Aust J Rural Health. 2022 Dec 27. doi: 10.1111/ajr.12957. Online ahead of print.NO ABSTRACTPMID:36573881 | DOI:10.1111/ajr.12957
Source: The Australian Journal of Rural Health - December 27, 2022 Category: Rural Health Authors: Beng Lim Alvin Chew Carlos Garcia-Esperon Sophie Dunkerton Neil J Spratt Source Type: research

Emergent readmission and long-term mortality risk after incident atrial fibrillation hospitalisation
Conclusion This study highlights the large burden of unplanned all-cause and cardiovascular-specific readmissions within 2 years after being hospitalised for incident AF and their associated adverse impact on mortality. Concomitant comorbidities are independently associated with unplanned hospitalisations and mortality, which supports integrated multidisciplinary management of comorbidities, along with AF-targeted treatments, to improve long-term outcomes in patients with AF.
Source: Heart - February 14, 2023 Category: Cardiology Authors: Weber, C., Hung, J., Hickling, S., Li, I., Murray, K., Briffa, T. Tags: Cardiac risk factors and prevention Source Type: research

Atrial Fibrillation (AF) Screening Within a Tertiary Hospital —A Baseline Study of Current Practice
This study aims to establish the current baseline of ECG practice within a hospital setting.
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: S. Mahendran, C. Chow, A. Thiagalingam Source Type: research

Rheumatic Heart Disease Echocardiogram Screening by Nonexperts: A Review
Rheumatic Heart Disease occurs when heart valves are damaged by Rheumatic Fever. Young First Nations Australians aged between 5 –14 years are at high risk of developing Rheumatic Fever. Complications of Rheumatic Heart Disease include atrial fibrillation, endocarditis, heart failure, and stroke. Early disease detection is essential as Acute Rheumatic Fever is easily treatable if detected early.
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: S. Stolic, O. Best, L. O'Malley, J. Elliott Source Type: research

Pages: 1  2  3  4  5